Nonepisodic angioedema with eosinophilia after COVID-19 vaccination: a case successfully treated with reslizumab

Our World In Data. Coronavirus (COVID-19) vaccinations [Internet], 2022. https://ourworldindata.org/covid-vaccinations. Accessed 02 Dec 2022.

Beatty AL, Peyser ND, Butcher XE, Cocohoba JM, Lin F, Olgin JE, Pletcher MJ, Marcus GM. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw Open. 2021;4(12): e2140364.

Article  Google Scholar 

Seirafianpour F, Pourriyahi H, Gholizadeh Mesgarha M, Pour Mohammad A, Shaka Z, Goodarzi A. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders. Dermatol Ther. 2022;35(6): e15461.

Article  CAS  Google Scholar 

Cooper BJ, Patterson R. Elevated IgM Levels, Edema, and Fatigue Syndrome. Arch Intern Med. 1976;136(12):1366–9.

Article  CAS  Google Scholar 

Gleich GJ, Schroeter AL, Marcoux JP, Sachs MI, O’Connell EJ, Kohler PF. Episodic angioedema associated with eosinophilia. N Engl J Med. 1984;310(25):1621–6.

Article  CAS  Google Scholar 

Nakachi S, Inokuma S. Eleven cases of angioedema with eosinophilia treated in a single hospital in Japan. Allergol Int. 2012;61(2):259–63.

Article  CAS  Google Scholar 

Cho HJ, Yoo HS, Kim MA, Shin YS, Ye YM, Nahm DH, et al. Clinical characteristics of angioedema with eosinophilia. Allergy Asthma Immunol Res. 2014;6(4):362–5.

Article  Google Scholar 

Chikama R, Hosokawa M, Miyazawa T, Miura R, Suzuki T, Tagami H. Nonepisodic angioedema associated with eosinophilia: report of 4 cases and review of 33 young female patients reported in Japan. Dermatology. 1998;197(4):321–5.

Article  CAS  Google Scholar 

Matsuda M, Fushimi T, Nakamura A, Ikeda S. Nonepisodic angioedema with eosinophilia: a report of two cases and a review of the literature. Clin Rheumatol. 2006;25(3):422–5.

Article  Google Scholar 

Butterfield JH, Leiferman KM, Abrams J, Silver JE, Bower J, Gonchoroff N, et al. Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood. 1992;79(3):688–92.

Article  CAS  Google Scholar 

Murakami T, Kato J, Kogawa K, Watanabe N, Sakamaki S, Kohgo Y, et al. Increased serum level of interleukin-5 in a patient with episodic angioedema and eosinophilia syndrome. Intern Med. 1993;2(4):343–5.

Article  Google Scholar 

Fettrelet T, Gigon L, Karaulov A, Yousefi S, Simon HU. The Enigma of eosinophil degranulation. Int J Mol Sci. 2021;22(13):7091.

Article  CAS  Google Scholar 

Khoury P, Herold J, Alpaugh A, Dinerman E, Holland-Thomas N, Stoddard J, et al. Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorder. Haematologica. 2015;100(3):300–7.

Article  CAS  Google Scholar 

Awaya T, Moroi M, Enomoto Y, Kunimasa T, Nakamura M. What Should We Do after the COVID-19 Vaccination? Vaccine-associated diseases and precautionary measures against adverse reactions. Vaccines (Basel). 2022;10(6):866.

Article  CAS  Google Scholar 

Kounis NG, Mplani V, Koniari I, Velissaris D. Hypersensitivity myocarditis and COVID-19 vaccines. Kardiol Pol. 2022;80(1):109–10.

Article  Google Scholar 

Takeda M, Ishio N, Shoji T, Mori N, Matsumoto M, Shikama N. Eosinophilic myocarditis following coronavirus disease 2019 (COVID-19) vaccination. Circ J. 2022;86(6):1020.

Article  CAS  Google Scholar 

Barrio Piqueras M, Ezponda A, Felgueroso C, Urtasun C, Di Frisco IM, Larrache JC, et al. Acute Eosinophilic Pneumonia following mRNA COVID-19 vaccination: a case report. Arch Bronconeumol. 2021;S0300–2896(21):00379–83.

Google Scholar 

Miqdadi A, Herrag M. Acute Eosinophilic Pneumonia Associated With the Anti-COVID-19 Vaccine. Cureus. 2021;13(10):e1895.

Google Scholar 

Chan-Chung C, Ong CS, Chan LL, Tan EK. Eosinophilic granulomatosis with polyangiitis after COVID-19 vaccination. QJM. 2022;114(11):807–9.

Article  CAS  Google Scholar 

Ikediobi O, Eichenfield DZ, Barrio VR. Eosinophilic cellulitis in response to BNT162b2 COVID-19 vaccination. Pediatr Dermatol. 2022. https://doi.org/10.1111/pde.15019.

Article  Google Scholar 

de Montjoye L, Marot L, Baeck M. Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine. J Eur Acad Dermatol Venereol. 2022;6(1):e26–8.

Google Scholar 

Kaikati J, Ghanem A, El Bahtimi R, Helou J, Tomb R. Eosinophilic panniculitis: a new side effect of Sinopharm COVID-19 vaccine. J Eur Acad Dermatol Venereol. 2022;36(5):e337–9.

Article  CAS  Google Scholar 

Lee JY, Lee JH. mRNA COVID-19 vaccine-associated subserosal Eosinophilic Gastroenteritis: a case report. J Korean Med Sci. 2022;37(30): e233.

Article  CAS  Google Scholar 

Ishizuka K, Katayama K, Kaji Y, Tawara J, Ohira Y. Non-episodic angioedema with eosinophilia after BNT162b2 mRNA COVID-19 vaccination Non-episodic angioedema with eosinophilia after BNT162b2 mRNA COVID-19 vaccination. QJM. 2021;114(10):745–6.

Article  CAS  Google Scholar 

Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol. 2020;146(1):1–7.

Article  CAS  Google Scholar 

Tseng CT, Sbrana E, Iwata-Yoshikawa N, Newman PC, Garron T, Atmar RL, et al. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PLoS ONE. 2012;7(4): e35421.

Article  CAS  Google Scholar 

Iwata-Yoshikawa N, Uda A, Suzuki T, Tsunetsugu-Yokota Y, Sato Y, Morikawa S, et al. Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine. J Virol. 2014;88(15):8597–614.

Article  Google Scholar 

Honda-Okubo Y, Barnard D, Ong CH, Peng BH, Tseng CT, Petrovsky N. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology. J Virol. 2015;89(6):2995–3007.

Article  CAS  Google Scholar 

Nagase H, Ueki S, Fujieda S. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis. Allergol Int. 2020;69(2):178–86.

Article  CAS  Google Scholar 

Rhyou HI, Han SH, Nam YH. Successful induction treatment of bullous pemphigoid using reslizumab: a case report. Allergy Asthma Clin Immunol. 2021;17(1):117.

Article  Google Scholar 

Chu HA, Youn DA, Park HA, Ye YA, Park YA, Ban GA. Non-episodic Angioedema With Eosinophilia Successfully Treated With Reslizumab. Allergy Asthma Immunol Res. 2020;12(2):371–4.

Article  Google Scholar 

留言 (0)

沒有登入
gif